Buture A, Tomkins EM, Shukralla A, Troy E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the Cephalalgia 2023;43:3331024231182126.
PMID: 37317535